AnaptysBio Inc (ANAB)
19.27
+0.09
(+0.47%)
USD |
NASDAQ |
Apr 24, 16:00
19.24
-0.03
(-0.16%)
After-Hours: 20:00
AnaptysBio Free Cash Flow (Quarterly): -34.63M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -34.63M |
September 30, 2023 | -36.64M |
June 30, 2023 | -25.60M |
March 31, 2023 | -24.74M |
December 31, 2022 | -10.86M |
September 30, 2022 | -17.80M |
June 30, 2022 | -24.22M |
March 31, 2022 | -21.07M |
December 31, 2021 | -25.32M |
September 30, 2021 | -7.178M |
June 30, 2021 | 8.728M |
March 31, 2021 | -23.52M |
December 31, 2020 | 37.27M |
September 30, 2020 | -17.10M |
June 30, 2020 | -19.69M |
March 31, 2020 | -15.20M |
December 31, 2019 | -15.91M |
September 30, 2019 | -22.38M |
Date | Value |
---|---|
June 30, 2019 | -15.76M |
March 31, 2019 | -16.28M |
December 31, 2018 | -12.50M |
September 30, 2018 | -15.18M |
June 30, 2018 | -9.182M |
March 31, 2018 | -12.71M |
December 31, 2017 | -4.934M |
September 30, 2017 | -3.901M |
June 30, 2017 | -2.711M |
March 31, 2017 | -8.182M |
December 31, 2016 | -5.571M |
September 30, 2016 | -3.073M |
June 30, 2016 | 1.655M |
March 31, 2016 | -2.091M |
December 31, 2015 | -2.694M |
September 30, 2015 | -1.915M |
June 30, 2015 | -2.699M |
March 31, 2015 | -2.624M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-36.64M
Minimum
Sep 2023
37.27M
Maximum
Dec 2020
-16.40M
Average
-19.69M
Median
Jun 2020
Free Cash Flow (Quarterly) Benchmarks
Fate Therapeutics Inc | -36.82M |
Ocular Therapeutix Inc | -22.91M |
Apellis Pharmaceuticals Inc | -97.97M |
Stoke Therapeutics Inc | -20.88M |
Vor Biopharma Inc | -24.14M |